GlassScriptPhysician profile
Edwin O Onkendi
NPI 1942432992
$9,332.78
in general payments reported to CMS, 2019-2025
21 companies · $2,460 in 2025
The $2,460 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $1,227 · 2021: $87.43 · 2022: $1,022 · 2023: $3,037 · 2024: $1,296 · 2025: $2,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $2,370 · Travel and Lodging: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $2,370.08 |
| Travel and Lodging | $1,923.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,685.71 | 2020-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Histosonics, INC. | $1,400.89 | 2025 | |
| Revance Therapeutics, INC. | $605.82 | 2024-2025 | Daxxify |
| Merz North America, INC. | $552.44 | 2021-2025 | |
| Abbvie INC. | $398.92 | 2023-2025 | |
| Boston Scientific Corporation | $200.55 | 2020-2024 | Spyglass Discover |
| Smith+Nephew, INC. | $102.47 | 2019-2025 | Stravix, Oasis |
| Davol INC. | $78.39 | 2020-2021 | |
| Olympus America INC. | $67.13 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $41.06 | 2019 | |
| Allergan, INC. | $33.59 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $28.82 | 2024 | Provenge |
| Lifenet Health | $19.54 | 2023 | |
| Z-Medica, LLC | $18.62 | 2019 | |
| Rigel Pharmaceuticals, INC. | $17.53 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $17.32 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.86 | 2022 | |
| Janssen Biotech, INC. | $13.27 | 2020 | |
| Eisai INC. | $12.23 | 2019 | |
| Genzyme Corporation | $11.80 | 2019 | |
| Amgen INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Onkendi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.